기본 정보
- 표준 SMILES
CCCCN1CCCCC1C(=O)Nc1c(C)cccc1C- InChIKey
LEBVLXFERQHONN-UHFFFAOYSA-N- 분자식
- C18H28N2O
- 평균 분자량
- 288.4 g/mol
- 단동위원소 질량
- 288.22016352
개요
1-butyl-N-(2,6-dimethylphenyl)piperidine-2-carboxamide is a piperidinecarboxamide obtained by formal condensation of the carboxy group of N-butylpipecolic acid with the amino group of 2,6-dimethylaniline. It is a piperidinecarboxamide, a tertiary amino compound and an aromatic amide. It is a conjugate base of a 1-butyl-2-[(2,6-dimethylphenyl)carbamoyl]piperidinium.
이름 및 식별자
- 우선 이름
- Bupivacaine (USAN:INN:BAN)
- IUPAC
- 1-butyl-N-(2,6-dimethylphenyl)piperidine-2-carboxamide
- 영어명
- Bupivacaine
- 분자식
- C18H28N2O
- 분자량
- 288.43
이름 및 동의어
이름 더 보기
데이터베이스 식별자
- CAS
2180-92-9、38396-39-3- PubChem CID
- 2474
- DTXSID
DTXSID2022703- ChEBI
CHEBI:77431- UNII
- Y8335394RO
- Nikkaji
- J7.351B
물성
구조 계산 물성
- XLogP
- 3.4
- 극성 표면적
- 32.3 Ų
- 수소 결합 공여자 수
- 1
- 수소 결합 수용자 수
- 2
- 회전 가능 결합 수
- 5
- 무거운 원자 수
- 21
- 형식 전하
- 0
- 복잡도
- 321
실험 및 물리화학적 성질
Collision Cross Section
173.1 Ų [M+H]+ [CCS Type: TW; Method: Major Mix IMS/Tof Calibration Kit (Waters)]
180.07 Ų [M+H-H2O]+ [CCS Type: TW; Method: calibrated with polyalanine and drug standards]
물리화학적 성질
- 녹는점
- 107.5 · 107.5-108°
- 끓는 점
- 430.65 °C · 430.65°C (rough estimate)
- 밀도
- 1.0238 · 1.0238 (rough estimate)
- 굴절률
- 1.57 · 1.5700 (estimate)
- 산도 계수 (pKa)
- 8.09 · 8.09; also reported as 8.17(at 25℃)
- 수용성
- 101.5 mg/L · 101.5mg/L(25℃)
- InChI
- InChI=1S/C18H28N2O/c1-4-5-12-20-13-7-6-11-16(20)18(21)19-17-14(2)9-8-10-15(17)3/h8-10,16H,4-7,11-13H2,1-3H3,(H,19,21)
- InChIKey
- LEBVLXFERQHONN-UHFFFAOYSA-N
- SMILES
- C1(CCCCN1CCCC)C(=O)NC1C(C)=CC=CC=1C
- NIST
- 2 · 2-Piperidinecarboxamide, 1-butyl-n-(2,6-dimethylphenyl)-(2180-92-9)
- EPA
- 2 · 2-Piperidinecarboxamide, 1-butyl-N-(2,6-dimethylphenyl)- (2180-92-9)
안전 및 규제
안전 데이터
- ridadr
- 2811
- risk_code
- 26/27/28-38-41
- hazard_code
- T+
- safety_code
- 22-26-36/37/39-45
화학 및 산업
약리 정보
용도 및 제조
응용 분야
용도Like lidocaine and mepivacaine, bupivacaine is used in infiltration, spinal, and epidural anesthesia in blocking nerve transmission. Its most distinctive property is its long-lasting action. It is used for surgical intervention in urology and in lower thoracic surgery from 3 to 5 h in length, and in abdominal surgery lasting from 45 to 60 min. It is used to block the trifacial nerve, the sacral and brachial plexuses, in resetting dislocations, in epidural anesthesia, and during Cesarian sections.
일반 설명Bupivacaine was synthesized simultaneously with mepivacainein 1957 but was at first overlooked because of the increasedtoxicity compared with mepivacaine. When themethyl on the cyclic amine of mepivacaine is exchanged fora butyl group the lipophilicity, potency and the duration ofaction all increase. Literature reports of cardiovascular toxicity,including severe hypotension and bradycardia, areabundant in the literature.91 Bupivacaine is highly bound toplasma proteins (95%), and thus the free concentration mayremain low until all of the protein binding sites are occupied.After that point, the plasma levels of bupivacaine rise rapidlyand patients may progress to overt cardiac toxicity withoutever showing signs of CNS toxicity. The cardiotoxicity ofbupivacaine is a result of its affinity to cardiac tissues and itsability to depress electrical conduction and predispose theheart to reentry types of arrhythmias. The cardiotoxicity ofbupivacaine was found to be significantly more prominentwith the “R” isomer, or the racemic mixture, thus the “S”stereoisomer is now on the market as levobupivacaine.
상·하류 제품 정보
상류 원료
공급사50 곳
관련 반응
연결된 노트
불러오는 중…